Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4 + T cells
Preprint
Abstract
SUMMARY: Type I interferon (IFN) upregulates proteins that inhibit HIV within infected cells. Prior studies have identified IFN-stimulated genes (ISGs) that impede lab-adapted HIV in cell lines, yet the ISG(s) that mediate IFN restriction in HIV target cells, primary CD4 + T cells, are unknown. Here, we interrogate ISG restriction of primary HIV in CD4 + T cells. We performed CRISPR-knockout screens using a custom library that specifically targets ISGs expressed in CD4 + T cells and validated top hits. Our investigation identified new HIV-restricting ISGs (HM13, IGFBP2, LAP3) and found that two previously studied factors (IFI16, UBE2L6) are IFN effectors in T cells. Inactivation of these five ISGs in combination further diminished IFN’s protective effect against six diverse HIV strains. This work demonstrates that IFN restriction of HIV is multifaceted, resulting from several effectors functioning collectively, and establishes a primary cell ISG screening model to identify both single and combinations of HIV-restricting ISGs.Keywords
All Related Versions
- Published version: Cell Reports, 42 (6), 112556.
This publication has 85 references indexed in Scilit:
- Host Gene Expression Changes Correlating With Anti–HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2aThe Journal of Infectious Diseases, 2012
- Global landscape of HIV–human protein complexesNature, 2011
- Origins of HIV and the AIDS PandemicCold Spring Harbor Perspectives in Medicine, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Interferon-Stimulated Gene 15 and the Protein ISGylation SystemJournal of Interferon & Cytokine Research, 2011
- Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa‐2a in HIV‐1–Monoinfected Participants: A Phase II Clinical TrialThe Journal of Infectious Diseases, 2010
- Signal peptide peptidase (SPP) assembles with substrates and misfolded membrane proteins into distinct oligomeric complexesBiochemical Journal, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeysNature, 2004
- Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid dropletsThe EMBO Journal, 2002